top of page

Olympia Weight Loss

OWMP is designed to use Low Dose Naltrexone (LDN) in addition to Sermorelin and Lipo-Trim SL, for best results. All medications work slightly differently to help the body raise growth hormone levels which supports several health benefits, including weight loss.


May help decrease insulin levels which can improve growth hormone levels in patients. Growth hormone helps the body burn fat and maintain lean muscle mass. May help normalize appetite and reduce hunger. In some studies has shown to reduce general inflammation throughout the body. Naltrexone may help to "normalize" this mismatch between calories burned and appetite, especially in patients with hormonal imbalances.

Naltrexone is an oral opiate receptor antagonist. It is derived from thebaine and is very similar in structure to oxymorphone. Like parenteral naloxone, naltrexone is a pure antagonist (i.e., agonist actions are not apparent), but naltrexone has better oral bioavailability and a much longer duration of action than naloxone. Clinically, naltrexone is used to help maintain an opiate-free state in patients who are known opiate abusers. Naltrexone is of greatest benefit in patients who take the drug as part of a comprehensive occupational rehabilitative program or other compliance-enhancing program. Unlike methadone or LAAM, naltrexone does not reinforce medication compliance and will not prevent withdrawal. Naltrexone has been used as part of rapid and ultrarapid detoxification techniques. These techniques are designed to precipitate withdrawal by administering opiate antagonists. These approaches are thought to minimize the risk of relapse and allow quick initiation of naltrexone maintenance and psychosocial supports. Ultrarapid detoxification is performed under general anesthesia or heavy sedation. While numerous studies have been performed examining the role of these detoxification techniques, a standardized procedure including appropriate medications and dose, safety, and effectiveness have not been determined in relation to standard detoxification techniques.18 Naltrexone supports abstinence, prevents relapse, and decreases alcohol consumption in patients treated for alcoholism. Naltrexone is not beneficial in all alcoholic patients and may only provide a small improvement in outcome when added to conventional therapy. The FDA approved naltrexone in 1984 for the adjuvant treatment of patients dependent on opiate agonists. FDA approval of naltrexone for the treatment of alcoholism was granted January 1995. The FDA approved Vivitrol, a once-monthly intramuscular naltrexone formulation used to help control cravings for alcohol in April 2006, and then in October 2010, the FDA approved Vivitrol for the prevention of relapse to opioid dependence after opioid detoxification.



Sermorelin may stimulate the pituitary to produce more of your own body’s growth hormone. Growth hormone production drops naturally as we age. Increased growth hormone can increase development of lean body mass through the development of new muscle cells. Higher growth hormone levels may reduce body fat through lipolysis



  • A concentrated sublingual oral spray which includes a combination of amino acids and B vitamins. Recommended dosage is 6 sprays or 1ml daily.

  • Can help the body convert fat into energy May help reduce cravings Can help support immune system

bottom of page